How The Study Was Built The investigators used the TriNetX US Collaborative Network and identified 841,831 eligible adult women with breast cancer across 68 healthcare organizations
( Figure 5 ) Briefly, SGLT2i inhibits the SGLT receptors in the proximal tubule, which inhibits the reabsorption of glucose from primary urine, resulting in glycosuria and a decrease in HbA1c and fasting glucose levels ( Figure 5 Clinical implications Given the significant cardioprotective effect of SGLT2i and GLP-1RAs, the ADA guidelines state that all diabetic patients with confirmed or subclinical cardiovascular disease should be prescribed a GLP-1RA class or SGLT2i class with proven cardiovascular benefit, regardless of the patients HbA1c level or the presence of other glucose-lowering medications ( Strengths and limitations To the best of our knowledge, this is the first meta-analysis to assess the effects of SGLT2i and GLP-1RAs as first-line therapeutic agents in T2DM patients with low cardiovascular disease risk
The chemokines comprise a family of small (8-14 kDa) chemotactic cytokines that can be divided into sub-families on the basis of structural motifs
FVN has received consultancy fees and/or research support from AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Novartis and Ultragenyx
PlexusDx patients achieve comparable weight-loss outcomes to Ozempic users at a fraction of the cost
Melanotan-II was initially studied for its effects on pigmentation through melanocortin receptor-1 (MC-1R)
